Ovid Therapeutics Inc. (OVID)
NASDAQ·Healthcare·Biotechnology
$2.86
+0.70%
Mkt Cap $556.60M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (11 analysts)
$6.25
Range $5.00 – $8.00
Implied Upside
+118.5%
Consensus $6.25 vs current $2.86
NASDAQ·Healthcare·Biotechnology
$2.86
+0.70%
Mkt Cap $556.60M
Buy
2
Hold
0
Sell
0
Price Target (11 analysts)
$6.25
Range $5.00 – $8.00
+118.5%
Consensus $6.25 vs current $2.86